Bio-Techne expands AI-engineered protein portfolio for cell therapy

Go back to Bio-Techne expands AI-engineered protein portfolio for cell therapy
Techne Corp (NASDAQ: TECH) Delayed: 72.10 +0.07 (0.10%)
Previous Close $72.03    52 Week High $117.42 
Open $72.02    52 Week Low $79.95 
Day High $72.14    P/E 23.33 
Day Low $71.99    EPS $3.09 
Volume 700,314